摘要

<正>日本吹田国立脑和心血管中心脑血管内科的Miwa等对THAWS试验(THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial)进行了一项二次分析, 旨在探讨急性卒中患者静脉溶栓后新发脑微出血(cerebral microbleed, CMB)的发生率和临床影响。THAWS是一项